SLC5A2 and type 2 diabetes mellitus: Furthermore, an abnormal QRS-T angle, another index of ventricular repolarization heterogeneity and a predictor for SCD (63), has been reported to be improved by SGLT2 inhibitors in patients with type 2 diabetes mellitus with known cardiovascular diseases (64).